Evolution of the health economics of cervical cancer vaccination

This publication has 36 references indexed in Scilit:

• The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada
  Vaccine, 2007
• Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland
  British Journal of Cancer, 2007
• Model for Assessing Human Papillomavirus Vaccination Strategies
  Emerging Infectious Diseases, 2007
• Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK
  British Journal of Cancer, 2006
• Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer
  Vaccine, 2006
• Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination
  Vaccine, 2006
• Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses
  PLoS Medicine, 2006
• The global health burden of infection‐associated cancers in the year 2002
  International Journal of Cancer, 2006
• Valuing Prevention Through Economic Evaluation
  PharmacoEconomics, 2004
• Cytological screening and management of abnormalities in prevention of cervical cancer: an overview with stochastic modelling.
  Journal of Clinical Pathology, 1994